Summary
The mitotic response to phytohaemagglutinin (PHA) was determined in lymphocytes of mothers and their newborn infants obtained at delivery and seven days later by measuring the rate of '25I-idoxuridine uptake into DNA in lymphocytes cultured in their own plasma and after washing and resuspension in fetal bovine serum. There was no difference in the unstimulated counts of maternal lymphocytes taken at delivery, whether unwashed or washed, compared with those from nonpregnant controls. With PHA stimulation the mitotic response of the maternal lymphocytes cultured in their own plasma was reduced compared with that of-the control lymphocytes but washed maternal cells showed a similar response to the controls. These findings suggest that the reduced lymphocyte mitotic response to PHA in pregnancy is due to a plasma inhibitory factor. This inhibition was not evident in maternal blood taken seven days after delivery.
DNA synthesis in unstimulated cultures from newborn infants at birth and seven days after birth was greater than that in adult control cultures. With PHA stimulation the mitotic response of cord-blood lymphocytes cultured in their own plasma paralleled that of control lymphocytes but washed newborn cells showed a greater response. Thus plasma suppression similar to that observed in the mother seems also to affect infants at birth. This inhibition was not demonstrable in blood taken from infants of 7 days.
Introduction
In most pregnant women the mitotic response of their lymphocytes to phytohaemagglutinin (PHA) is reduced (Purtilo et al., 1972) , but the process by which this response, which seems to be predominantly the property of T cells, is reduced is uncertain (Purtilo et al., 1972; Walker et al., 1972) . A recent study indicated the presence of a serum inhibitor in pregnancy (St Hill et al., 1973) but its nature and origin is unknown. There are several conflicting reports on the response of cord-blood lymphocytes to PHA (Lindahl-Kiessling and Book, 1964; Leikin et al., 1968; Meuwissen et al., 1968; Jones, 1969; Campbell et al., 1975) .
We have studied the mitotic responses to PHA of the lymphocytes of mothers and their newborn infants, obtained at delivery and seven days later. To investigate the presence of an inhibitory plasma factor we also compared the PHA responses of lymphocytes cultured in the presence of autologous plasma with those after washing the cells and resuspending them in fetal bovine serum.
Patients and Methods
Collection of Blood Samples.-Blood samples were obtained by venepuncture from 24 mothers at delivery, and 24 samples of cord blood were collected from their newborn infants at the same time. In each case 5 ml of blood was anticoagulated with preservative-free heparin and an EDTA sample was taken for a white cell and differential count. All samples were cultured within 24 hours of collection and in most cases within 12 hours.
With each batch of samples tested control samples of venous blood, taken from age-nmatched healthy non-pregnant women, were treated in the same manner. Blood samples were also obtained from 13 of the mothers and their infants seven days after delivery and were similarly treated.
Preparation of Cultures.-A whole-blood microtechnique similar to that described by Maini et al. (1973) was used in setting up -the cultures. Tubes were set up in triplioate each containing 1 ml of rminimal essential medium (M.E.M.) supplemented with glutamine, non-essential amino-acids, and antibiotics to which 0-1 ml of the b!ood sample was added. PHA (Wellcome, dried reagent, lot K6888) was added to a concentration of 1/100. Triplicate tubes were also set up without added PHA. Preparations of washed cells were made by first diluting 2 ml of the blood sample with 20 ml of M.E.M. under which about 4 ml of heat-inactivated fetal bovine serum (Biocult, batoh 000239) was lavered. The cells were then centrifuged th-rough the layer of fetal bovine serum and the autologous plasma removed by sucking off the supernatant until 2 ml remained. After resuspension of the cells 01 ml was added to each culture tube and similarly treated as the unwashed cell cultures.
Assessment of Lymphocyte Response to PI-LA.-The cultures were incubated for 72 hours at 37°C. DNA sythesis was estimated by incorporation of 125I-idoxuridine (Craig et al., 1969) . A stock solution of this reagent (Radiochemical Centre, Amersham) was made up with added cold deoxyuridine to a concentration 10 mg/l and an activity of 20 mCi/l. From this solution 0-05 ml (1 pCi) was added to each tube three hours before the end of culture after taking off 0 5 ml of culture medium. At the end of the culture the cells were spun down and the supernatant containing the excess isotope decanted off. Red cells were lysed by washing with 2%/o acetic acid in normal saline, and the residue was washed and spun down sequentially in normal saline, 10°% trichloroacetic acid (twice), and methanol. This extreme washing was necessary to reduce to low levels the isotope activity not specifically bound to the material precipitated by trichloroacetic acid. .. .. ! 5>1, P <0-001 5 >1, P <0-001 5>1, P <0-005 5>1, P <0-005 graft survival of skin in pregnant women (Andresen and Monroe, 1962) . Our findings further indicate that this reduction in T-cell response in pregnancy is no longer obvious seven days after delivery. Our observation that the depressed maternal lymphocyte response to PHA returned to normal after washing the cells and removing autologous plasma from the culture provides direct evidence of an inhibitory factor in the mother's own plasma. Seven days after delivery, however, the effect of the inhibitor was not apparent. Pregnant sera may suppress the PHA response of normal adult lymphocytes (Walker et al., 1972; St Hill et al., 1973; Leikin, 1972) . Various hormones, including corticosteroids (Whitfield et al., 1968) , progesterone (Munroe, 1971) , oestrogen (Waltman et al., 1971) , and chorionic gonadotrophin (Kaye and Jones, 1971) , show immunosuppressive properties. Depressed lymphocyte response to PHA in women taking oral contraceptives also suggests a nonspecific oestrogen or progesterone action (Hagan and Forland, 1972; Fitzgerald et al., 1973; Barnes, 1974) . Carcinoembryonic antigen (Gold, 1967) , a-globulin (Cooperband et al., 1968) , placental glycoprotein (Riggio et al., 1971) , and c-fetal protein (Purves and Geddes, 1972) have also exhibited immunosuppressive properties.
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Spontaneous blast transformation of cord-blood lymphocytes in control cultures without PHA has been reported to be higher (Leikin et al., 1968; Pulvertaft and Pulvertaft, 1966) , similar to (Jones, 1969) , and less than (Lindahl-Kiessling and Book, 1964) that of adult lymphocytes. Recent studies of DNA synthesis with radioactive tagging showed significantly higher background counts for unstimulated cells in cord-blood samples than for adult control cells (Montgomery et al., 1973 ) and our present and earlier observations (Campbell et al., 1974) (Jones, 1969; Montgomery et al., 1973; Ayoub and Kasakura, 1971) , and others have shown them to parallel that of adult cells (Leikin et al., 1968; Meuwissen et al., 1968) . Others showed that the response of cord-blood lymphocytes was higher than that of adult control lymphocytes (Lindalh-Kiessling and B6ok, 1964; Campbell et al., 1974) . Our results confirm these latter reports but only when the cells were cultured with autologous plasma removed. This inhibitory effect of newborn plasma on the infants' own cells was not obvious seven days after birth. Fetal sera suppress the PHA response of normal adult lymphocytes (Ayonb and Kasakura, 1971) and it was postulated that separate molecules were responsible for the inhibitory effect in maternal and fetal sera (Kasakura, 1971) . A recent study, however, suggested that fetal serum has a greater depressive action than maternal serum and hence the inhibitor may be derived from the fetal-placental unit (St Hill et al., 1973) . The nature of the inhibitory factor is unknown and further studies are required to clarify its nature and source of this plasma inhibitory factoras well as its role in the survival of the fetal allograft in human pregnancy.
